Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Timing of feeding tube may protect muscle mass in esophageal cancer fight

NCT ID NCT06712706

First seen Apr 25, 2026 · Last updated May 23, 2026 · Updated 5 times

Summary

This study involved 60 adults with advanced esophageal cancer who were scheduled for chemotherapy and surgery. Some received a feeding tube early, at the time of diagnosis, while others got it later during surgery. The goal was to see if early tube feeding helps prevent muscle loss (sarcopenia), a common problem that can lead to worse outcomes. Researchers measured muscle mass at three points: diagnosis, before surgery, and six months after surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Stadtspital Zürich

    Zurich, 8063, Switzerland

Conditions

Explore the condition pages connected to this study.